|
EPC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.17780000489176E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.85400000486081E-08 |
| Normal-vs-Stage2 |
5.80459999999228E-05 |
| Normal-vs-Stage3 |
1.382120E-03 |
| Normal-vs-Stage4 |
2.15040000000055E-05 |
| Stage1-vs-Stage2 |
9.388000E-01 |
| Stage1-vs-Stage3 |
5.202800E-01 |
| Stage1-vs-Stage4 |
4.206600E-01 |
| Stage2-vs-Stage3 |
5.899000E-01 |
| Stage2-vs-Stage4 |
2.907800E-01 |
| Stage3-vs-Stage4 |
1.812800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.99489999969305E-08 |
| Normal-vs-AfricanAmerican |
1.34500000004145E-06 |
| Normal-vs-Asian |
5.935400E-03 |
| Caucasian-vs-AfricanAmerican |
9.743600E-01 |
| Caucasian-vs-Asian |
9.748200E-01 |
| AfricanAmerican-vs-Asian |
9.610400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99140004486509E-09 |
| Normal-vs-Female |
1.951880E-02 |
| Male-vs-Female |
5.523100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.6939899999957E-05 |
| Normal-vs-Extreme_Weight |
2.56190000325063E-08 |
| Normal-vs-Obese |
4.07490000000621E-05 |
| Normal-vs-Extreme_Obese |
1.74204999999761E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.806400E-01 |
| Normal_Weight-vs-Obese |
2.184800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.196200E-01 |
| Extreme_Weight-vs-Obese |
8.658400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.239000E-01 |
| Obese-vs-Extreme_Obese |
1.102600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.583800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.584100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.4604998300789E-10 |
| Normal-vs-Age(81-100Yrs) |
1.28040000002549E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.173400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.405250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.387600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.877600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.423800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.446600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.90680000070154E-08 |
| Normal-VS-Type2 PRCC |
3.02099999460737E-08 |
| Normal-VS-KIRP CIMP |
2.773500E-04 |
| Normal-VS-Unclassified PRCC |
3.554200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.774400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.440800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.921900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.894600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.149800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.590950E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.40359998571194E-09 |
| Normal-vs-N1 |
1.475160E-03 |
| Normal-vs-N2 |
1.164700E-03 |
| N0-vs-N1 |
6.464500E-02 |
| N0-vs-N2 |
7.558600E-01 |
| N1-vs-N2 |
2.992400E-01 |
|
|
